Meribank Biotech Co., Ltd (TPEX:4724)
Taiwan · Delayed Price · Currency is TWD 9.06
-0.13 (-1.41%)
Aug 4, 2026, 1:51 PM CST
Meribank Biotech Market Cap
Meribank Biotech has a market cap or net worth of 872.42 million as of August 4, 2026. Its market cap has decreased by -45.36% in one year.
Market Cap
872.42M
Enterprise Value
1.78B
Revenue
471.76M
Ranking
n/a
PE Ratio
n/a
Stock Price
9.06
ChartMarket Cap Chart
Since June 16, 2023, Meribank Biotech's market cap has decreased from 1.95B to 872.42M, a decrease of -55.17%. That is a compound annual growth rate of -22.57%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 4, 2026 | 872.42M | -39.35% |
| Dec 31, 2025 | 1.44B | -41.61% |
| Dec 31, 2024 | 2.46B | 2.99% |
| Dec 29, 2023 | 2.39B | 22.90% |
| Jun 16, 2023 | 1.95B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| U-Neuron Biomedical | 1.09B |
| Bio Preventive Medicine | 1.07B |
| Level Biotechnology | 1.03B |
| GeneReach Biotechnology | 994.21M |
| Lukas Biomedical | 979.86M |
| Holy Stone Healthcare | 912.34M |
| TCI GENE | 899.59M |
| Taiwan Advance Bio-Pharmaceutical | 808.20M |